4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-23-053508
Options or other derivatives
- Chief Scientific Officer acquired 300,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Janhofer Guenter · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-10-23 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +300,000 | 300,000 | D |
Loading xslF345X05/doc4.xml…